The U.S. Food and Drug Administration has amended the emergency use authorizations of the Moderna and Pfizer COVID-19 vaccines to allow their use as a single booster dose in children.
The Moderna COVID-19 Vaccine, Bivalent, is authorized for administration at least two months following completion of primary or booster vaccination in children at least six years of age.
